Beaver-Visitec recalls Wet-Field Hemostatic Eraser Bipolar 25G with incorrect labeling. Affected units have Part Number 221267 and UDI 30886158010549. No remedy specified in recall notice.
“Beaver-Visitec Wet-Field Hemostatic Eraser Bipolar 25G Recall: Incorrect Labeling.” GovInfoNow, updated August 28, 2026. https://govinfonow.com/recall/71866-beaver-visitec-wet-field-hemostatic-eraser-bipolar-25g-recall-incorrect. Based on FDA recall #Z-1801-2018 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1801-2018%22&limit=1).
Beaver-Visitec International, Inc. recalled Wet-Field Hemostatic Eraser Bipolar 25G units due to incorrect labeling, the FDA said on Feb. 26, 2018. The agency announced the Class II recall of 1,025 units distributed in the U.S. and Canada.
How to tell if you have it
Brand: Beaver-Visitec
Product: Wet-Field Hemostatic Eraser Bipolar 25G, fine tip, straight, 5/SP
Part Number: 221267
UDI: 30886158010549
Lot number: 6001035
The hazard
The products were packaged with incorrect labeling, according to the FDA. The recall involved 1,025 units distributed nationwide in the U.S. and Canada.
Context
GovInfoNow's records show Beaver-Visitec International, Inc. has 15 other recalls on record since Nov. 3, 2017. Other recent recalls of similar products include HydroMARK Breast Biopsy Marker Recall (April 24, 2026), Boston Scientific FARASTAR Ablation Generator EU Recall (June 11, 2026) and Boston Scientific FARASTAR Ablation Generator Recall (June 11, 2026).
How to tell if you have this one
Check for Part Number 221267 and Unique Device Identifier (UDI) 30886158010549 on the packaging. The product was manufactured in Lot 6001035.
Brand
Beaver-Visitec
Category
Medical device
Based on the official FDA remedy
What to do — step by step
Check Product Labeling
Verify the Part Number 221267 and UDI 30886158010549 on the packaging to confirm if the product is affected.
Where it went and when
Where it was distributed
Distributed nationwide, and outside the U.S.
Nationwide
Not listed
FDA distribution: “US Nationwide and Canada” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide, and outside the U.S.
Recall timeline
FDA terminated this recall 20 months after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #Z-1801-2018 (February 26, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1801-2018 to see it in context.
Plain-language summary written by qwen3:4b on August 28, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.